Mayo Clinic Represents at CAP16 Advancing Diagnostic Medicine—The Pathologists’ Meeting

screen-shot-2016-11-04-at-11-20-40-amMayo Clinic had a very strong representation at the CAP16 Pathologists’ Meeting—Advancing Diagnostic Medicine. The meeting was held September 25–28 in Las Vegas. See the list of platform presentations and abstracts below.

Congratulations to everyone involved for providing a strong Mayo Clinic presence at this year’s conference.

Platform Presentations

“Long-Term Outcome Study of Papillary Urothelial Carcinoma of the Urinary Bladder, A Comparison of WHO 1973 with WHO/ISUP 2004 Grading Systems”
Xiaotun Zhang, M.B.

Abstracts (Posters)

Traditional Serrated Adenoma Versus Villous Adenoma with Ectopic Crypt Foci
Heidi Lehrke, D.O.; Bradley Anderson, M.D.; David Ahlquist, M.D.; Thomas Smyrk, M.D.

MEF2B Is Frequently Expressed in Pediatric Burkitt Lymphoma and Correlates to Germinal Center Type of Pediatric Diffuse Large B-Cell Lymphoma
David Marbury, M.D.; Benjamin Chilcutt; Rebecca King, M.D.; Jason Schallheim, M.D.; Lisa Sullivan, M.D.; Siraj El Jamal, M.D.

Florid Papillomatosis of the Nipple and Subsequent Development of Mammary Carcinoma
Rosalind  Sandell, M.D.; Michael  Keeney, M.D.; Teresa  Allers; Marlene Frost, Ph.D.; Amy Degnim, M.D.; Lynn Hartmann, M.D.; Daniel Visscher, M.D.

Morphometric Study of Vascular Changes in Pulmonary Langerhans Cell Histiocytosis
Melanie Bois, M.D.; Adam May, M.D.; Robert Vassallo, M.D.; Sarah Jenkins; Eunhee Yi, M.D.; Anja Roden, M.D.

Ciliated Muconodular Papillary Tumors Arising in Non-Asian Patients: Report of 4 Cases and Confirmation of BRAF V600E Mutation
Liping Liu, M.D., Ph.D.; Scott Aesif, M.D., Ph.D.; Benjamin Kipp, Ph.D.; Jesse Voss, CT; Marie Christine Aubry, M.D.; Jennifer Boland, M.D.

Cyclin-D1 Loss and CD44 Expression in Metastatic Castration-Resistant Prostate Cancer, with and without Neuroendocrine Differentiation
Georgios Deftereos, M.D.; Colm Morrissey, Ph.D.; Xiaotun Zhang, M.D.; Lawrence True, M.D.; Maria Tretiakova, M.D., Ph.D.

Long-Term Outcome Study of Papillary Urothelial Carcinoma of the Urinary Bladder: A Comparison of WHO 1973 with WHO/ISUP 2004 Grading Systems
Xiaotun Zhang, M.D.; Sarah Jenkins; John Cheville, M.D.; Jun Zhang, M.D.

Implementation of a Software Application for Presurgical and Intraoperative Review of Frozen-Section Pathology Cases
Andrew Norgan, M.D., Ph.D.; Justin Juskewitch, M.D., Ph.D.; Matthew Okeson

INI1 Mutated Sinonasal Carcinoma in a 16-Year-Old Adolescent Girl: First Report of a Rare Entity in Pediatric Population and Its Key Diagnostic Points
Ramin Zargham, M.D., Ph.D.; Michael Rivera, M.D.

Hemophagocytic Syndrome Associated with Disseminated Histoplasmosis in a Patient with Rheumatoid Arthritis
Andrew Norgan, M.D., Ph.D.; Curtis Hanson, M.D.; Bobbi Pritt, M.D.

Catching Cutaneous Amebic Infection Prior to Lethal Dissemination
Toshi Ghosh, M.D.; Julio Sartori-Valinotti, M.D.; Lawrence Gibson, M.D.; Jason Weiss, D.O.; Bobbi Pritt, M.D.

Sclerosing Rhabdomyosarcoma in Heart: First Report of a Rare Entity in an Unusual Location
Ramin Zargham, M.D., Ph.D.; Diva Salomao, M.D.

kschrib

Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.